Hamilton Lane Advisors LLC Collegium Pharmaceutical, Inc Transaction History

Hamilton Lane Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 22, 2019	SELL	$13.58 - $18.72 $1.22 Million - $1.68 Million	-89,975 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$14.78 - $19.68 $362,316 - $482,435	-24,514 Reduced 21.41%	89,975 $1.54 Million
Q3 2018 Oct 16, 2018	BUY	$14.16 - $24.3 $903,393 - $1.55 Million	63,799 Added 125.86%	114,489 $2,000
Q2 2018 Jul 31, 2018	SELL	$21.79 - $28.29 $297,150 - $385,790	-13,637 Reduced 21.2%	50,690 $1,000
Q1 2018 May 03, 2018	BUY	$18.15 - $29.21 $1.17 Million - $1.88 Million	64,327 New	64,327 $2,000

250

36.7M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.14B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.